Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 37.37 USD 2.75% Market Closed
Market Cap: $1.7B

P/B

1.4
Current
4%
Cheaper
vs 3-y average of 1.4

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
1.4
=
Market Cap
$1.5B
/
Total Equity
$1.2B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
1.4
=
Market Cap
$1.5B
/
Total Equity
$1.2B

Valuation Scenarios

Omnicell Inc is trading below its 3-year average

If P/B returns to its 3-Year Average (1.4), the stock would be worth $38.84 (4% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+129%
Average Upside
63%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 1.4 $37.37
0%
3-Year Average 1.4 $38.84
+4%
5-Year Average 1.8 $50.08
+34%
Industry Average 3.1 $85.4
+129%
Country Average 2.5 $68.77
+84%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close
Market Cap P/B P/E
US
Omnicell Inc
NASDAQ:OMCL
1.7B USD 1.4 820
JP
Medical Data Vision Co Ltd
TSE:3902
37.9T JPY 20.7 227.5
US
Cerner Corp
LSE:0R00
31.3B USD 8 53.1
US
Veeva Systems Inc
NYSE:VEEV
26.4B USD 3.7 29
AU
Pro Medicus Ltd
ASX:PME
14.5B AUD 36.7 60.8
JP
M3 Inc
TSE:2413
1T JPY 2.6 20.5
SE
Sectra AB
STO:SECT B
51.8B SEK 26.8 96.4
US
Waystar Holding Corp
NASDAQ:WAY
4.9B USD 1.2 42.4
US
Doximity Inc
NYSE:DOCS
4.4B USD 4.5 18.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
18.7B CNY 3.3 -60.8
US
Vocera Communications Inc
F:V00
2.4B EUR 17.2 -328
P/E Multiple
Earnings Growth PEG
US
Omnicell Inc
NASDAQ:OMCL
Average P/E: 152
820
285%
2.9
JP
Medical Data Vision Co Ltd
TSE:3902
227.5
62%
3.7
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
29
27%
1.1
AU
Pro Medicus Ltd
ASX:PME
60.8
29%
2.1
JP
M3 Inc
TSE:2413
20.5
16%
1.3
SE
Sectra AB
STO:SECT B
96.4
14%
6.9
US
W
Waystar Holding Corp
NASDAQ:WAY
42.4
55%
0.8
US
Doximity Inc
NYSE:DOCS
18.6
15%
1.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -60.8
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A

Market Distribution

Lower than 73% of companies in the United States of America
Percentile
27th
Based on 10 946 companies
27th percentile
1.4
Low
0 — 1.5
Typical Range
1.5 — 4.8
High
4.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.5
Median 2.5
70th Percentile 4.8
Max 147 580.5

Omnicell Inc
Glance View

Omnicell Inc. stands at the intersection of healthcare and technology, sculpting the landscape of medication management systems with its innovative spirit. Founded in 1992, Omnicell has evolved from a small enterprise into a leading provider of automated solutions for medication and supply dispensing, inventory management, and analytics. The company’s core offering, its automated dispensing systems, reshapes how hospitals, pharmacies, and healthcare providers manage medications. By utilizing cutting-edge technology, Omnicell improves efficiency, reduces medication errors, and cuts down on healthcare costs. These systems are embedded in the workflow of healthcare facilities, ensuring that medication management becomes seamless, thus elevating patient safety and clinical outcomes. Revenue streams flow robustly from both product sales and associated services. Omnicell garners income by selling its advanced hardware systems, which include everything from pharmacy carousels to medication robotic systems, and supplements these sales with software solutions that offer predictive analytics and inventory optimization. Beyond the initial sale, a significant part of their business model includes recurring revenue through service contracts, software updates, and customer support. This dual approach not only ensures a steady cash flow but also strengthens customer relationships by consistently providing value over time. As the healthcare industry increasingly leans on technology for streamlined operations and cost management, Omnicell’s strategic positioning allows it to capitalize on the demand for sophisticated medication management solutions.

OMCL Intrinsic Value
38.04 USD
Undervaluation 2%
Intrinsic Value
Price $37.37
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett